Multicentre phase II studies evaluating imatinib plus hydroxyurea in patients with progressive glioblastomaDavid A. Reardon, Zariana Nikolova, Martin J. van den Bent et al.|British Journal of Cancer|2009Cited by 130
Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised studyMark Rosenthal, Warren Mason, Paul M. Clément et al.|ESMO Open|2020Cited by 35